These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
173 related articles for article (PubMed ID: 24560658)
1. Reply to "Response to locoregional treatment and alpha-fetoprotein trend in liver transplant candidates for HCC: dwarfs standing on the shoulders of giants". Otto G J Hepatol; 2014 Jun; 60(6):1332-3. PubMed ID: 24560658 [No Abstract] [Full Text] [Related]
2. Response to locoregional treatment and alpha-fetoprotein trend in liver transplant candidates for HCC: dwarfs standing on the shoulders of giants. Lai Q; Avolio AW; Graziadei I; Lerut J; J Hepatol; 2014 Jun; 60(6):1331-2. PubMed ID: 24560664 [No Abstract] [Full Text] [Related]
3. Reply to: "How to decide about liver transplantation in patients with hepatocellular carcinoma: size and number of lesions or response to TACE?". Otto G J Hepatol; 2014 Feb; 60(2):464-5. PubMed ID: 24216447 [No Abstract] [Full Text] [Related]
4. Tumor biology and pre-transplant locoregional treatments determine outcomes in patients with T3 hepatocellular carcinoma undergoing liver transplantation. Kim PT; Onaca N; Chinnakotla S; Davis GL; Jennings LW; McKenna GJ; Ruiz RM; Levy MF; Goldstein R; Klintmalm GB Clin Transplant; 2013; 27(2):311-8. PubMed ID: 23351129 [TBL] [Abstract][Full Text] [Related]
5. How to decide about liver transplantation in patients with hepatocellular carcinoma: size and number of lesions or response to TACE? Paul A; Sotiropoulos G; Gerken G; Saner FH J Hepatol; 2014 Feb; 60(2):463-4. PubMed ID: 24216443 [No Abstract] [Full Text] [Related]
6. Surgical resection and liver transplantation for hepatocellular carcinoma. Akoad ME; Pomfret EA Clin Liver Dis; 2015 May; 19(2):381-99. PubMed ID: 25921669 [TBL] [Abstract][Full Text] [Related]
11. Downstaging disease in patients with hepatocellular carcinoma outside of Milan criteria: strategies using drug-eluting bead chemoembolization. Green TJ; Rochon PJ; Chang S; Ray CE; Winston H; Ruef R; Kreidler SM; Glueck DH; Shulman BC; Brown AC; Durham J J Vasc Interv Radiol; 2013 Nov; 24(11):1613-22. PubMed ID: 24060436 [TBL] [Abstract][Full Text] [Related]
12. How to decide about liver transplantation in patients with hepatocellular carcinoma: size and number of lesions or response to TACE? Otto G; Schuchmann M; Hoppe-Lotichius M; Heise M; Weinmann A; Hansen T; Pitton MP J Hepatol; 2013 Aug; 59(2):279-84. PubMed ID: 23587474 [TBL] [Abstract][Full Text] [Related]
14. Effectiveness of locoregional therapy before living donor liver transplantation in patients with hepatocellular carcinoma who meet the Milan criteria. Kim JM; Kwon CH; Joh JW; Choi MS; Lee JH; Koh KC; Paik SW; Kim GS; Kim SJ; Lee SK; Yoo BC Transplant Proc; 2012 Mar; 44(2):403-8. PubMed ID: 22410028 [TBL] [Abstract][Full Text] [Related]
15. Without victory there is no survival: transarterial lipiodol chemoembolization and hepatocellular carcinoma. Sudan D; Sudan R; Schafer D; Langnas A Hepatology; 1998 Jul; 28(1):270-1. PubMed ID: 9657124 [No Abstract] [Full Text] [Related]
16. Clinical profile and liver explant findings in patients with and without pretransplant downstaging for hepatocellular carcinoma. Felga G; Evangelista AS; Salvalaggio PR; Curvelo LA; Della Guardia B; Almeida MD; Afonso RC; Ferraz-Neto BH Transplant Proc; 2012 Oct; 44(8):2399-402. PubMed ID: 23026605 [TBL] [Abstract][Full Text] [Related]
17. Non-resective ablation therapy for hepatocellular carcinoma: effectiveness measured by intention-to-treat and dropout from liver transplant waiting list. Fisher RA; Maluf D; Cotterell AH; Stravitz T; Wolfe L; Luketic V; Sterling R; Shiffman M; Posner M Clin Transplant; 2004 Oct; 18(5):502-12. PubMed ID: 15344951 [TBL] [Abstract][Full Text] [Related]
18. Liver transplantation for hepatocellular carcinoma: lessons learned and future directions. Levi DM; Nishida S Clin Liver Dis; 2011 Nov; 15(4):717-25. PubMed ID: 22032525 [TBL] [Abstract][Full Text] [Related]
19. [Influence of treatment of hepatocellular carcinoma before liver transplantation on post transplant tumor recurrence and survival]. Díaz-Sánchez A; Matilla A; Núñez O; Merino B; Peligros I; Rincón D; Salcedo M; Lo Iacono O; Vega Catalina M; Clemente G; Bañares R Gastroenterol Hepatol; 2010 Mar; 33(3):155-64. PubMed ID: 19945770 [TBL] [Abstract][Full Text] [Related]
20. Hepatocellular carcinoma: from ethanol injection to liver transplantation. Bismuth H; Majno P; Adam R Acta Gastroenterol Belg; 1999; 62(3):330-41. PubMed ID: 10547900 [No Abstract] [Full Text] [Related] [Next] [New Search]